Full-Time

Clinical Trial Associate

Confirmed live in the last 24 hours

Fractyl Health

Fractyl Health

51-200 employees

Therapies for Type 2 Diabetes treatment

Biotechnology
Healthcare

Junior, Mid

Burlington, MA, USA

Requires 0% - 5% travel.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Google Cloud Platform
Requirements
  • Bachelor’s degree in scientific or business field of study
  • 1-3 years of experience at a Pharmaceutical, Biotech, Medical Device Company, CRO, or equivalent site experience
  • Direct experience in preparing and delivering Start-Up activities
  • Proficient in Microsoft Office (e.g., Word, Excel, and PowerPoint), Google docs and web‐based systems
  • Applicable experience in biotech, pharmaceutical and/or medical device industries preferred
  • Prior vocational experience in related fields a plus (i.e. Co-Ops, Internships, Fellowships, etc.)
  • Understanding of complexities of study start up
  • Desire to learn and expand knowledge and skillset
  • Self‐motivated individual who can work autonomously, as well as working as a member of teams
  • Must be highly adaptable to competing deadlines and changes in priorities
  • Must have a strong attention to detail
  • Successful track record of working in high-growth and dynamic organizations
  • Demonstrated record of intellectual curiosity, innovation and creative problem solving with an entrepreneurial spirit
  • Ability to lead fast-paced projects with a keen sense of urgency to get the job done well
  • Evidence of 'hands-on' experience and expertise
  • Proven and successful track record as a team-player and collaborator in small working environments
  • Highly organized and detail oriented with a passion to deliver quality results
  • Excellent verbal and written communication skills, with experience translating technical concepts into user-friendly documentation
  • Highest levels of professionalism, confidence, personal values and ethical standards
Responsibilities
  • Support the Clinical Operations team in the successful execution of clinical trials from protocol concept to clinical trial report, complying with international ICH/Good Clinical Practice (GCP) guidelines/regulations and Standard Operating Procedures (SOPs)
  • Assist project teams with trial progress by updating study trackers
  • Submit clinical documents in quality management system for management and team approval
  • Perform all activities in compliance with applicable regulations, Fractyl’s policies and guidelines, including, but not limited to, timely documentation of activities and maintaining all required applicable training.
  • Bring a 'can do' spirit to work and deliver on other responsibilities as assigned.
  • Help coordinate site regulatory document review and approvals
  • Help Sr Specialist manage IRB/EC and regulatory submission and approvals, including amendments and continuing reviews
  • Maintain SSU documents in internal TMF and maintain inspection ready documentation
  • Arrange, organize, and maintain clinical study documentation, including but not limited to, preparing for internal/external audits, final reconciliation, and archival
  • Support the development of slides and presentations materials
  • Perform Trial Master File (TMF) reviews to ensure completeness and audit‐readiness
  • Request, manage, distribute and track study supplies (Regulatory Binders, Study Reference Manuals, Patient Diaries, consumables & ancillary supplies, etc.)
  • Support overall vendor coordination (process document updates, systems coordination, supplies coordination, etc.)

Fractyl focuses on creating therapies for Type 2 Diabetes (T2D) and obesity, targeting the underlying causes of these conditions. Their main product, Rejuva, is a gene therapy designed to enhance the function of pancreatic islet cells, which are essential for blood sugar regulation. By improving these cells, Fractyl aims to help patients achieve long-term remission from T2D and obesity. Unlike many competitors, Fractyl is in the preclinical stage with Rejuva, which has received a CE mark for commercial availability in Europe, although it is still awaiting full FDA approval. The company's goal is to develop effective treatments that can prevent and eliminate these metabolic diseases.

Company Stage

IPO

Total Funding

$282.2M

Headquarters

Lexington, Kentucky

Founded

2010

Growth & Insights
Headcount

6 month growth

0%

1 year growth

19%

2 year growth

21%
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing interest in minimally invasive therapies aligns with Fractyl's focus.
  • Gene therapy market projected to grow, benefiting Fractyl's Rejuva platform.
  • European CE mark aids Fractyl's commercialization efforts in the region.

What critics are saying

  • Competition from Eli Lilly's Mounjaro may impact Fractyl's market share.
  • FDA scrutiny on gene therapies could delay Rejuva platform approval.
  • Reimbursement challenges in the US may affect Rejuva's adoption rates.

What makes Fractyl Health unique

  • Fractyl Health focuses on minimally invasive therapies for chronic diseases.
  • Revita DMR rejuvenates the duodenum lining, improving patient health.
  • Rejuva platform targets pancreatic islet cells for long-term T2D remission.

Help us improve and share your feedback! Did you find this helpful?